AURKB and lung carcinoma: In vitro assays showed that GSK 1070916 conferred a dose-dependent inhibition of histone H3 phosphorylation, a specific substrate of AURKB and conveyed anti-tumor effects in ten human tumor xenografts, including lung cancer [69].